230 related articles for article (PubMed ID: 15625613)
21. Treatment of acute asthma: salbutamol via jet nebuliser vs spacer and metered dose inhaler.
Robertson CF; Norden MA; Fitzgerald DA; Connor FL; Van Asperen PP; Cooper PJ; Francis PW; Allen HD
J Paediatr Child Health; 1998 Apr; 34(2):142-6. PubMed ID: 9588637
[TBL] [Abstract][Full Text] [Related]
22. Drug delivery in asthma: a comparison of spacers with a jet nebuliser.
Gibson PG; Wlodarczyk JH; Borgas T
Aust N Z J Med; 1995 Aug; 25(4):324-9. PubMed ID: 8540873
[TBL] [Abstract][Full Text] [Related]
23. Methacholine challenge tests to demonstrate therapeutic equivalence of terbutaline sulfate via different Turbuhaler
Bjermer L; Gauvreau GM; Postma DS; O'Byrne PM; van den Berge M; Boulet LP; Beckman O; Persson T; Román J; Carlholm M; Schützer KM; Eckerwall G
Pulm Pharmacol Ther; 2017 Jun; 44():1-6. PubMed ID: 28232118
[TBL] [Abstract][Full Text] [Related]
24. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.
Seppälä OP; Herrala J; Hedman J; Alanko K; Liipo K; Terho E; Pietinalho A; Nyholm JE; Nieminen MM
Respir Med; 1998 Mar; 92(3):578-83. PubMed ID: 9692126
[TBL] [Abstract][Full Text] [Related]
25. Assessment of different methods of inhalation from salbutamol metered dose inhalers by urinary drug excretion and methacholine challenge.
Tomlinson HS; Corlett SA; Allen MB; Chrystyn H
Br J Clin Pharmacol; 2005 Dec; 60(6):605-10. PubMed ID: 16305584
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer.
Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G
Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619
[TBL] [Abstract][Full Text] [Related]
27. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device.
Gunawardena KA; Sohal T; Jones JI; Upchurch FC; Crompton GK
Respir Med; 1997 May; 91(5):311-6. PubMed ID: 9176650
[TBL] [Abstract][Full Text] [Related]
28. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
[TBL] [Abstract][Full Text] [Related]
29. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
Langley SJ; Houghton CM; Singh SD
Respiration; 2005; 72 Suppl 1():35-7. PubMed ID: 15915011
[TBL] [Abstract][Full Text] [Related]
30. The course of inhalation profiles during an exacerbation of obstructive lung disease.
Broeders ME; Molema J; Hop WC; Vermue NA; Folgering HT
Respir Med; 2004 Dec; 98(12):1173-9. PubMed ID: 15588037
[TBL] [Abstract][Full Text] [Related]
31. Proof-of-concept evaluation of trough airway hyper-responsiveness following regular racemic or levosalbutamol in genotype-stratified steroid-treated persistent asthmatic patients.
Anderson WJ; Short PM; Williamson PA; Morrison AE; Palmer C; Tavendale R; Lipworth BJ
Clin Sci (Lond); 2014 Jan; 126(1):75-83. PubMed ID: 23829494
[TBL] [Abstract][Full Text] [Related]
32. Randomised controlled study of clinical efficacy of spacer therapy in asthma with regard to electrostatic charge.
Dompeling E; Oudesluys-Murphy AM; Janssens HM; Hop W; Brinkman JG; Sukhai RN; de Jongste JC
Arch Dis Child; 2001 Feb; 84(2):178-82. PubMed ID: 11159302
[TBL] [Abstract][Full Text] [Related]
33. Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube.
Fowler SJ; Wilson AM; Griffiths EA; Lipworth BJ
Chest; 2001 Apr; 119(4):1018-20. PubMed ID: 11296163
[TBL] [Abstract][Full Text] [Related]
34. Low-dose salbutamol suppresses airway responsiveness to histamine but not methacholine in subjects with asthma.
Matsumoto K; Aizawa H; Fukuyama S; Yoshida M; Komori M; Takata S; Koto H; Inoue H
Respir Investig; 2013 Sep; 51(3):158-65. PubMed ID: 23978642
[TBL] [Abstract][Full Text] [Related]
35. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices.
Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K
Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791
[TBL] [Abstract][Full Text] [Related]
36. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.
Chuffart AA; Sennhauser FH; Wildhaber JH;
Swiss Med Wkly; 2001 Jan; 131(1-2):14-8. PubMed ID: 11205181
[TBL] [Abstract][Full Text] [Related]
38. Formoterol turbuhaler is as effective as salbutamol diskus in relieving adenosine-induced bronchoconstriction in children.
Amirav I; Yacobov R; Luder AS
J Aerosol Med; 2007; 20(1):1-6. PubMed ID: 17388747
[TBL] [Abstract][Full Text] [Related]
39. Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the Turbuhaler in asthmatic individuals.
Derom E; Borgström L; Van Schoor J; Löfroos AB; Pauwels R
Am J Respir Crit Care Med; 2001 Oct; 164(8 Pt 1):1398-402. PubMed ID: 11704585
[TBL] [Abstract][Full Text] [Related]
40. Regular inhaled salbutamol and airway responsiveness to allergen.
Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
